Details for: RALIVIA
Company: BAUSCH HEALTH, CANADA INC.
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02299194 | RALIVIA | TRAMADOL HYDROCHLORIDE | 100 MG | TABLET (EXTENDED-RELEASE) | ORAL |
| 02299208 | RALIVIA | TRAMADOL HYDROCHLORIDE | 200 MG | TABLET (EXTENDED-RELEASE) | ORAL |
| 02299216 | RALIVIA | TRAMADOL HYDROCHLORIDE | 300 MG | TABLET (EXTENDED-RELEASE) | ORAL |
Summary Reports
Summary Safety Review - Tramadol-containing Products - Assessing the Potential Risk of Serious Breathing Problems (Respiratory Depression) in Children and Adolescents
Summary Safety Review - Tramadol-containing products - Assessing the Potential Risk of Hallucinations
Summary Safety Review - Tramadol-containing products - Assessing the Potential Risk of Hallucinations
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.